Table III.
Remission of treatment outcomes between the two groups.
| Item | Total remission rate (n=90) | Weekly protocol (n=46) | Daily scheme (n=44) |
|---|---|---|---|
| Photophobia | 42 (75.0) | 22/26 (84.6) | 20/30 (66.7) |
| Lacrimation | 42 (70.0) | 18/26 (69.2) | 24/34 (70.6) |
| Swelling | 46 (76.7) | 18/26 (69.2) | 28/34 (82.4) |
| Grittiness | 48 (82.8) | 34/34 (100.0) | 14/24 (58.3) |
| Diplopia | 18 (56.2) | 8/16 (50) | 10/16 (62.5) |
| Vision loss | 38 (67.9) | 18/26 (69.2) | 20/30 (66.7) |
| Pain | 38 (67.9) | 14/26 (53.8) | 24/30 (80.0) |
Values are expressed as n (%). No significant difference was found between the daily scheme and weekly protocol.